Clinical Trials Browser

Erythroplasia, Leukoplakia, Oral

NCT02581137 2026-04-13

Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion

Phase 2 Active not recruiting

26 enrolled 10 charts

Head & Neck

Erythroplasia, Hyperplasia, Leukoplakia, Oral, Mouth Neoplasms

NCT00542373 2026-03-05

Widefield Fluorescence and Reflectance Imaging Systems and Oral Tissue Samples in Monitoring Participants at Risk for Developing Oral Cancer

Phase NA Active not recruiting

338 enrolled

Classical hematologyDermatologicHead & Neck

Erythroplasia, Fanconi Anemia, Lichen Planus, Mouth Neoplasms, Tobacco Use Disorder, Leukokeratosis, Hereditary Mucosal

NCT06325514 2025-06-04

Artificial Intelligence Based Program to Classify Oral Cavity Findings Based on Clinical Image Analysis

Completed

241 enrolled

Head & Neck

Erythroplasia, Leukoedema, Oral, Leukoplakia, Mouth Neoplasms, Lichenoid Eruptions, Lichen Planus, Oral

NCT05536037 2025-05-15

Metformin for the Prevention of Oral Cancer in Patients With Oral Premalignant Lesions

Phase 1 Terminated

4 enrolled

Head & Neck

Erythroplasia, Leukoplakia, Mouth Neoplasms

NCT04622462 2024-11-07

Early Prediction of Oral Cancer by S100A7 Immunohistochemistry Signature-based Assessment

Recruiting

500 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Disease, Erythroplasia, Hyperplasia, Leukoplakia, Mouth Neoplasms, Keratoderma, Palmoplantar, Epidermolytic

NCT05853783 2024-11-07

Evaluation of Oral Potentially Malignant Disorders (OPMDs) with STRATICYTE™

Recruiting

180 enrolled

Head & Neck

Disease, Erythroplasia, Hyperplasia, Leukoplakia, Mouth Diseases, Keratoderma, Palmoplantar, Epidermolytic

NCT05296941 2023-09-08

PMOD

Phase NA Recruiting

200 enrolled

Head & Neck

Erythroplasia, Leukoplakia, Mouth Neoplasms, Lichen Planus, Oral

NCT04079491 2023-02-16

Intra and Extra Oral Inspection of Oral Mucosa

Terminated

70 enrolled

Head & Neck

Erythroplasia, Leukoplakia, Oral, Lichen Planus, Oral

NCT03939364 2021-10-19

This Study is to Evaluate the Safety and Pharmacokinetics of SBS-101 in Patients With Oral Premalignant Lesions

Phase 1 Withdrawn

Head & Neck

Erythroplasia, Leukoplakia, Oral

NCT03990636 2019-06-19

PDTMALAC

Phase 2 Unknown

40 enrolled

Head & Neck

Actinic cheilitis, Erythroplasia, Leukoplakia

NCT00179361 2018-03-02

Natural History of Oro-pharyngeal Cancer Precursors

Completed

374 enrolled

Head & NeckOther neoplasm

Erythroplasia, Leukoplakia, Precancerous Conditions

NCT00571974 2015-03-24

Treatment of Oral Premalignant Lesions With 5-ALA PDT

Phase 1/2 Completed

29 enrolled 6 charts

Head & Neck

Erythroplasia, Leukoplakia

Clinical Trials

Metformin for the Prevention of Oral Cancer in Patients With Oral Leukoplakia or Erythroplakia

Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion

Widefield Fluorescence and Reflectance Imaging Systems and Oral Tissue Samples in Monitoring Participants at Risk for Developing Oral Cancer

Artificial Intelligence Based Program to Classify Oral Cavity Findings Based on Clinical Image Analysis

Metformin for the Prevention of Oral Cancer in Patients With Oral Premalignant Lesions

Early Prediction of Oral Cancer by S100A7 Immunohistochemistry Signature-based Assessment

Evaluation of Oral Potentially Malignant Disorders (OPMDs) with STRATICYTE™

PMOD

Intra and Extra Oral Inspection of Oral Mucosa

This Study is to Evaluate the Safety and Pharmacokinetics of SBS-101 in Patients With Oral Premalignant Lesions

PDTMALAC

Natural History of Oro-pharyngeal Cancer Precursors

Treatment of Oral Premalignant Lesions With 5-ALA PDT